Background Exercise-associated hyponatraemia (EAH) is a potentially fatal cause of collapse in endurance exercise. It is understood to be a dilutional hyponatraemia caused by an increase of total body water relative to the amount of exchangeable sodium stores. Fourteen runners presented to one London hospital with symptomatic EAH several hours after fi nishing the 2003 London Marathon, and more recently, a young male runner died from the complications of severe EAH after crossing the fi nish line of the London Marathon. Objectives To determine the incidence of EAH in runners in the London Marathon. Methods Volunteers were recruited at race registration where they were weighed, had blood tests and completed a demographic and experience questionnaire. Weights, blood tests and a fl uid intake questionnaire were repeated after the fi nish. Blood was analysed on-site using hand-held i-STAT blood analysers. Results Of the 88 volunteers, 11 (12.5%) developed asymptomatic hyponatraemia (serum sodium 128-134 mmol/l). They consumed more fl uid (p<0.001) and gained more weight (p<0.001) than did those without hyponatraemia. Conclusions A signifi cant proportion (12.5%) of healthy volunteers developed asymptomatic hyponatraemia running a marathon in cool conditions. On average, these runners consumed more fl uid and gained more weight than did non-hyponatraemic runners, although fl uid intake was not related to weight gain in this study. Four of the 11 hyponatraemic runners lost weight over the course of the marathon, strengthening the case for an additional factor, such as inappropriate antidiuretic hormone release during exercise, in the development of EAH.
INTRODUCTION
Over 710 000 runners have successfully completed the London Marathon in its 28-year history. While it is generally considered to be a safe event, medical staff at the marathon assess and treat up to 2% of runners annually for problems ranging from muscle cramps and exercise-associated collapse to hyperthermia and cardiac arrest. Marathon runners are at risk of collapse from causes related to exercise 1 not commonly seen in the general population. A life-threatening cause of collapse during endurance exercise is exercise-associated hyponatraemia (EAH), which has been responsible for the deaths of at least fi ve runners in the USA and UK in the last few years. [2] [3] [4] [5] EAH is defi ned as serum sodium concentration ([Na + ]) less than 135 mmol/l during or up to 24 h after prolonged physical activity. 4 The disorder is broadly classifi ed into symptomatic or asymptomatic hyponatraemia by the presence or absence of signs or symptoms rather than by the absolute value of [Na + ] as this is not a reliable predictor of clinical severity. 4 Early signs and symptoms of hyponatraemia are non-specifi c such as bloating, nausea, vomiting and headache. The more severe manifestations of hyponatraemia, hyponatraemic encephalopathy caused by cerebral oedema, can lead to confusion, seizures, coma and death. 4 EAH is widely understood to be a dilutional hyponatraemia caused by an increase of total body water relative to the amount of exchangeable sodium stores. 4 Aetiological factors include excessive fl uid consumption in excess of total body fl uid losses, 4 6 altered renal function, 3 7 longer race duration, 8 female gender 9 and smaller size. 6 Excessive sodium loss may also have an impact on the development of EAH, although it has not been shown to be a primary causative factor. 4 In an attempt to reduce the morbidity and mortality associated with EAH, the International EAH Consensus Development Conference has met twice in recent years, publishing Consensus Statements with recommendations for fl uid replacement during endurance exercise. 4 10 Guidance has also been produced by the American College of Sports Medicine 11 and the International Marathon Medical Directors Association. 12 Yet in studies on volunteers running marathons in Europe and the USA, the incidence of hyponatraemia is between 3% and 22%. 13 14 After running the London Marathon in 2003, 14 runners presented to one London hospital with symptomatic EAH. 15 More recently, a young male runner died of pulmonary and cerebral oedema consequent to EAH after crossing the fi nish line of the London Marathon. 5 This study aimed to examine the incidence of hyponatraemia in fi nishers in the London Marathon.
METHOD

Study setting
The London Marathon is a full 42.2 km marathon held over a fl at city course in the spring. Bottles of water (330 ml) are available from water stations situated every mile (1.6 km) from the third mile onwards. Additionally, 330 ml sachets of a sports drink containing 22 mmol/l [Na + ] 16 are available at 4.6, 8.8, 15.3 and 23.7 miles. Runners are advised in the prerace literature not to drink at every station and not to drink excessively.
Study population
Healthy volunteers were recruited at race registration from runners participating in the 2006 London Marathon. Written consent was obtained from each volunteer. Each was weighed in light clothing and completed a questionnaire detailing demographics and marathon experience. A 2 ml sample of venous blood was drawn from the antecubital fossa and analysed immediately for sodium on self-calibrating, handheld i-STAT blood analysers (Abbott Point of Care, East Windsor, New Jersey, USA). (The i-STAT analyser has been shown to have excellent reliability for measuring [Na + ] when compared to simultaneous laboratory analyser measurements. 17 18 It has been used with success in the marathon setting 14 19 and has been in use in the medical tents of the London Marathon since 2005.) As soon as possible after fi nishing the marathon, volunteers were asked to report to the medical tent on-site where they were weighed on the same scales, had a postrace blood test analysed in the same fashion as before and completed a fl uid intake questionnaire. Estimated fl uid intake was calculated by multiplying the number of drinks consumed by 330 ml (the volume of a water bottle or sports drink sachet.)
Statistical analysis
Statistics were calculated using GraphPad Prism (GraphPad Software, San Diego, California, USA). Descriptive statistics were used to illustrate demographics and to estimate the incidence of hyponatraemia. Differences between groups were analysed with independent t tests for continuous variables, χ 2 for categorical variables and Mann-Whitney U tests for non-parametric data. Where appropriate, skewed data were transformed to a logarithmic scale to follow a normal distribution. Relationships between continuous variables were analysed using Pearson's Product Moment correlation and linear regression. Data are presented as "mean (SD)" unless otherwise stated. Signifi cance was defi ned as p<0.05.
RESULTS
The event was held in wet, rainy conditions with air temperature 9-12°C, humidity 73% and wind speed 3-9 km/h. Wet bulb globe temperature (WBGT) was 9°C at the start. The race started with 33 578 runners; 33 222 fi nished. At the fi nish, 603 runners were seen in the medical tents. No cases of symptomatic EAH were found among these runners.
Volunteers Demographics
One hundred and sixteen volunteers were recruited. Prerace data sets on fi ve runners were incomplete, and they were not included in further analysis. The remaining 111 comprised 42 female and 69 male runners with an average age of 38.8 years. Eighty-eight of these 111 (79.3%) returned for postrace tests after the marathon. The returning runners had a lower baseline [Na + ] (138 (3) mmol/l, p=0.044) and ran the marathon 33 min faster (p=0.005) than did those who did not return for blood tests (baseline [Na + ] 140 (2) mmol/l) (fi gure 1). Otherwise, the two groups were not signifi cantly different in terms of age, sex, body mass index (BMI) or previous experience.
All except two non-returners fi nished the marathon. One did not start the race, and another withdrew after tripping and injuring her leg. A third runner collapsed after fi nishing and was reviewed by the medical team. His [Na + ] was found to be 138 mmol/l, excluding the diagnosis of EAH.
Postrace results
Asymptomatic hyponatraemia was identifi ed in 11 (12.5%) of the 88 volunteers. Their [Na + ] ranged from 128 to 134 mmol/l. This group was not signifi cantly different from the volunteers Postrace [Na + ] was inversely related to fl uid intake (r 2 =0.160, p<0.001) (fi gure 3) as well as to absolute weight change (r 2 =0.133, p<0.001) and relative weight change (r 2 =0.140, p<0.001) (fi gure 4). These relationships were similar when the change in [Na + ] was modelled against fl uid intake (r 2 =0.169, p<0.001) and absolute (r 2 =0.096, p=0.003) and relative weight change (r 2 =0.097, p=0.003). Although there was a positive trend between fl uid intake and weight change, this relationship was not signifi cant (p=0.217).
DISCUSSION
Principal fi ndings
Eleven of a control group of 88 healthy volunteers (12.5%) running the London Marathon had asymptomatic hyponatraemia that did not develop hyponatraemia in terms of age (p=0.412), sex (p=0.084, χ 2 =2.989), prerace weight (p=0.429), BMI (p=0.231) or previous marathon experience (median number of previous marathons: p=0.545; proportion with experience: p=0.865, χ 2 =0.029) (table 1). There was no signifi cant difference in fi nishing times between hyponatraemic and non-hyponatraemic runners (table 2) . There were no cases of symptomatic hyponatraemia.
Fluid intake
Average fl uid intake over the course of the marathon was 2144 ml; however, runners who developed hyponatraemia reported a signifi cantly larger fl uid intake (3683 ml vs 1924 ml, p=0.001) and consumed fl uid at a higher rate than those without hyponatraemia (843 ml/h vs 451 ml/h, p=0.002) (table 2). There was no difference in frequency of drinking (p=0.138) or frequency of urination (p=0.099) during the race. Runners who developed hyponatraemia reported drinking more fl uid in the time between fi nishing and their postrace review than did those who did not develop hyponatraemia, but this difference was not statistically signifi cant (271 vs 186 ml, p=0.200).
Weight change
Runners with hyponatraemia completed the marathon 0.46 (1.65) kg heavier than their baseline weight, while those without hyponatraemia lost 1.46 (1.70) kg (p<0.001) over the same period. Relative weight change was also signifi cantly different between the two groups (0.76 (2.8)% vs −1.9 (−2.2)%, p<0.001) (table 2).
Sodium changes
Runners who developed hyponatraemia had a lower baseline [Na + ] (albeit within the normal reference range) than those who did not develop hyponatraemia. They also exhibited a greater fall in [Na + ] than those without hyponatraemia (table 3) . 
However, in this study, estimated fl uid intake was not related to weight gain. Several reasons may account for this. First, fl uid intake was self-reported and subject to recall bias. Second, runners should expect to lose some weight over the course of a marathon due to substrate oxidation; 21 neutral weight balance therefore suggests over-hydration. A recent study calculated that weight loss of 0.75 kg was the minimum necessary over the course of a marathon to reduce the risk of developing hyponatraemia. 14 Finally, weight gain and subsequent EAH may be related to factors other than fl uid intake. The volumes consumed by participants in this study were on the whole not exceptional quantities, although the differences between the two groups are signifi cant. The larger group of 77 unaffected runners drank less than 2 litres each over the course of the race, while runners who developed hyponatraemia drank an average of over 3.5 litres per person. Unaffected runners drank at an average rate of 450 ml/h; hyponatraemic runners drank at the fi nish. On average, these runners consumed more fl uid and gained more weight than did non-hyponatraemic runners, although fl uid intake was not related to weight gain in this study, and four of the 11 hyponatraemic runners lost weight over the course of the marathon. Female gender and slow race pace were not associated with the development of EAH in this study. Five of the 11 runners who developed hyponatraemia fi nished the race within 4 h.
Discussion
The primary aetiological factor in the development of EAH is fl uid consumption in excess of total body fl uid losses. 4 6 8 Athletes drink more during exercise in hot conditions than in cool conditions, 20 and unusually hot environmental conditions are a recognised risk factor for EAH. 4 A cluster of 14 cases of EAH after a previous London Marathon was partly attributed to the hot conditions on the day (WBGT 15.2°C, 0.43 cases of symptomatic EAH per 1000 fi nishers); cooler conditions on each of the following 2 years were associated with only single cases (2004: WBGT 10.8°C, 0.03/1000; 2005: WBGT 12°C, 0.03/1000). 15 In the cool, wet conditions encountered during this current event, none of the collapsed runners seen by medical staff in the medical tents had hyponatraemia (unpublished data). However, despite these conditions, 12.5% of a group of healthy volunteers running the London Marathon drank suffi cient quantities of fl uid to lower their [Na + ] by an average of 6 mmol/l, thereby developing hyponatraemia.
Weight change is a useful objective measure of fl uid intake 6 and retention. 3 Consistent with data from the Boston Marathon, 6 hyponatraemic runners in this study reported a signifi cantly larger fl uid intake and exhibited considerable weight gain compared with non-hyponatraemic runners. Signifi cant inverse relationships between [Na + ] and weight change and [Na + ] and fl uid intake in this study lend support to the fi ndings of Almond et al, 6 providing further evidence for the role of excessive fl uid intake in the aetiology of EAH. 
of the hyponatraemic runners in this study consumed fl uid at rates (less than 450 ml/h) unlikely to cause fl uid overload purely by overwhelming the renal excretory capacity. Additionally, four hyponatraemic runners actually lost weight over the course of the run (two of these four consumed fl uid at less than 450 ml/h). Inappropriate antidiuretic hormone (ADH) release during exercise causing altered renal function and secondary fl uid retention is one such mechanism by which EAH can develop in the absence of excessive fl uid intake. 3 4 22 Inappropriate ADH release increases the risk of developing EAH even when relatively "normal" volumes of fl uid are consumed. 4 Non-osmotic stimulation of ADH causing EAH has been linked to the release of interleukin-6 in exertional rhabdomyolysis in marathon runners. 3 23 Evidence of inappropriately concentrated urine would be a useful surrogate marker of the syndrome of inappropriate secretion of antidiuretic hormone (SIADH) for future studies.
Recent experience from the London Marathon indicates that runners with hyponatraemia have tended to present to hospital several hours after fi nishing the event apparently well, suggesting that fl uid consumed after exercise may add to the risk of developing hyponatraemia. 3 8 One theory 19 24 suggests that as blood fl ow returns to the gut with the cessation of exercise and before the renal system has returned to normal, increased absorption of water from the gut contributes to fl uid overload and the subsequent risk of EAH. Runners in this study who developed hyponatraemia tended to drink more after the race than those who did not develop hyponatraemia, but this difference did not reach statistical signifi cance. Persistent SIADH may explain postrace onset of EAH as runners continue to consume fl uids under the mistaken impression that delayed urination signifi es dehydration. 3 For practical reasons, volunteers in this study were asked to report for follow-up blood tests as soon as possible after fi nishing the marathon. The incidence of hyponatraemia may well have been higher if blood samples had been taken later. Development of EAH in the hours after the marathon is worthy of further investigation.
EAH is more common after exercise of more than 4 h duration: slower runners have more opportunity to consume excessive volumes of fl uid. 6 8 9 25 In this study, however, fi ve of the 11 runners (45.5%) who developed hyponatraemia fi nished the race within 4 h, and, contrary to other studies, 8 the current study did not fi nd a correlation between fi nishing times and [Na + ]. Closer analysis reveals that three of these fi ve consumed at least 600 ml in the time between fi nishing and their review, thereby increasing their total fl uid intake by 25-30% after stopping exercise. These two observations enhance the case for the presence of an additional factor, such as altered renal function persisting after the precipitating activity, in the development of EAH.
A limitation noted by other studies was a lack of baseline or premarathon [Na + ]. 6 Without a baseline, it could be argued that development of hyponatraemia is related to low premarathon [Na + ]. Although those who developed hyponatraemia did start with a lower premarathon [Na + ], they were all within the normal range. Notably, however, these runners demonstrated a signifi cantly greater fall in [Na + ] than those who did not develop hyponatraemia.
The incidence of asymptomatic hyponatraemia in this study group is consistent with the experience at the Boston Marathon supporting the contention that EAH is underrecognised. 6 The tipping point at which asymptomatic hyponatraemia becomes symptomatic is highly variable and therefore unpredictable. Following Almond et al, if this incidence of EAH is representative of all fi nishers in the London Marathon, 4152 runners are likely to have fi nished with asymptomatic hyponatraemia, despite the cool wet weather conditions discouraging excessive drinking. This life-threatening condition, which recently claimed the life of a healthy runner in the London Marathon, 5 appears to remain a real threat despite recent EAH Consensus Statements 4 10 and an Advisory Statement from the International Marathon Medical Directors Association 12 on safe drinking habits during exercise. This signifi cant incidence of asymptomatic hyponatraemia which developed in cool running conditions in a healthy running population should alert marathon medical staff and organisers to the potential for an increase in more severe hyponatraemia in warmer weather conditions which encourage excessive drinking. Runners should continue to be educated about fl uid intake during exercise and the symptoms of early hyponatraemia such as weight gain.
Limitations
Logistical considerations determined that prerace weight and [Na + ] were measured at registration rather than at the start; thus, we cannot ascertain the true prerace hydration status of the volunteers immediately before the race. Fluid intake in this study was self-reported. Runners often take great care over their training and race schedules; however, fl uid intake was reported retrospectively and therefore must be treated as an estimate. Fortunately, weight change, a more reliable and objective measure of fl uid balance, 3 produced similar results.
Twenty-three volunteers (20.1%) did not return for a blood test after the marathon. There could be many reasons for this, but we do know this group fi nished the marathon later than those who did return. If prolonged duration of exercise is a recognised risk factor and had this group returned for blood tests, might the incidence of EAH have been even higher?
CONCLUSION
A signifi cant proportion (12.5%) of healthy volunteers developed asymptomatic hyponatraemia running a marathon in cool conditions. On average, these runners consumed more fl uid and gained more weight than did non-hyponatraemic runners, although fl uid intake was not related to weight gain in this study, and four of the 11 hyponatraemic runners lost weight over the course of the marathon. Female gender and slow race pace were not associated with the development of EAH in this study. Five of the 11 runners who developed hyponatraemia fi nished the race within 4 h. Three of these fi ve consumed up to 30% of their total fl uid intake after they had fi nished the marathon. These observations enhance the case for the presence of an additional factor in the development of EAH, such as inappropriate ADH release during exercise causing altered renal function and which may persist after cessation of the precipitating activity.
What is already known on this topic
Exercise-associated hyponatraemia (EAH) is a potentially fatal cause of collapse in endurance exercise. Risk factors include excessive fl uid consumption in excess of total body fl uid losses, altered renal function, longer race duration, female gender and smaller size. Five marathon runners are known to have died from EAH in recent years.
What this study adds
A signifi cant proportion (12.5%) of healthy volunteers developed asymptomatic hyponatraemia running a marathon in cool conditions. Although they consumed more fl uid and gained more weight than non-hyponatraemic runners, fl uid intake was not related to weight gain; several hyponatraemic runners lost weight. SIADH during exercise may potentially account for this phenomenon.
